These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 8899328)
21. Modification of antinociceptive action of Ukrain by endogenous nitric oxide in the writhing syndrome test in mice. Jagiello-Wójtowicz E; Kleinrok Z; Chodkowska A; Szkodziak A; Siembida E; Gustaw K; Urbanska E Drugs Exp Clin Res; 1998; 24(5-6):321-5. PubMed ID: 10190096 [TBL] [Abstract][Full Text] [Related]
22. Ukrain (NSC-631570) in experimental and clinical studies: a review. Jagiello-Wójtowicz E; Kleinrok Z; Urbanska EM Drugs Exp Clin Res; 1998; 24(5-6):213-9. PubMed ID: 10190077 [TBL] [Abstract][Full Text] [Related]
23. The influence of Ukrain on the growth of HA-1 tumor in mice: the role of cysteine proteinases as markers of tumor malignancy. Svechnikova IG; Korolenko TA; Stashko JuF ; Kaledin VI; Nikolin VP; Nowicky JW Drugs Exp Clin Res; 1998; 24(5-6):261-9. PubMed ID: 10190085 [TBL] [Abstract][Full Text] [Related]
24. Mitogenic properties of Ukrain (NSC-6315170) on human peripheral blood monocytes: clinical implications. Jin YM; Nowicky JW; Liepins A Drugs Exp Clin Res; 1996; 22(3-5):99-101. PubMed ID: 8899311 [TBL] [Abstract][Full Text] [Related]
25. Influence of Ukrain on immunological blood parameters in vitro and in vivo. Nowicky JW; Hiesmayr W; Liepins A Drugs Exp Clin Res; 1996; 22(3-5):163-5. PubMed ID: 8899322 [TBL] [Abstract][Full Text] [Related]
26. Comparative in vitro study of the effects of the new antitumor drug Ukrain and several cytostatic agents on the thiol groups in the tissue of Guerin carcinoma and its resistance to cisplatin variant. Kulik GI Drugs Exp Clin Res; 1998; 24(5-6):277-80. PubMed ID: 10190087 [TBL] [Abstract][Full Text] [Related]
27. Proapoptotic activity of Ukrain is based on Chelidonium majus L. alkaloids and mediated via a mitochondrial death pathway. Habermehl D; Kammerer B; Handrick R; Eldh T; Gruber C; Cordes N; Daniel PT; Plasswilm L; Bamberg M; Belka C; Jendrossek V BMC Cancer; 2006 Jan; 6():14. PubMed ID: 16417634 [TBL] [Abstract][Full Text] [Related]
28. Radiomodification effects of Ukrain, a cytostatic and immunomodulating drug, on intracellular glucocorticoid reception during short-term gamma-irradiation. Luksa-Lichtenthaeler GL; Ladutko EI; Nowicky JW Drugs Exp Clin Res; 2000; 26(5-6):311-5. PubMed ID: 11345044 [TBL] [Abstract][Full Text] [Related]
29. Effect of Ukrain on the growth and metastasizing of Lewis carcinoma in C57BL/6 mice. Grinevich Y; Shalimov S; Bendyuh G; Zahriychuk O; Hodysh Y Drugs Exp Clin Res; 2005; 31(2):59-70. PubMed ID: 15929607 [TBL] [Abstract][Full Text] [Related]
30. Synergic influence of Ukrain and protoporphyrin amino acid conjugates on human malignant cell lines. Brzosko WJ; Graczyk A; Konarski J; Nowicky JW Drugs Exp Clin Res; 1996; 22(3-5):193-4. PubMed ID: 8899329 [TBL] [Abstract][Full Text] [Related]
31. Effect of single and three months treatment with Ukrain on aminotransferases (ALT and AST) and on the serum protein level in rodents. Jagiełło-Wójtowicz E; Kleinrok Z; Surmaczyńska B; Baran E; Feldo M; Nowicky JW Drugs Exp Clin Res; 1992; 18 Suppl():85-7. PubMed ID: 1305051 [TBL] [Abstract][Full Text] [Related]
32. Amino acids and their derivatives in tumour tissue from patients with breast cancer treated with Ukrain. Part VI. Nefyodov LI; Uglyanica KN; Smirnov VY; Doroshenko YM; Fomin KA; Nowicky JW; Brzosko WJ Drugs Exp Clin Res; 1996; 22(3-5):159-61. PubMed ID: 8899321 [TBL] [Abstract][Full Text] [Related]
34. Pharmacological effects of Ukrain in rats and rabbits. Remiszewska M; Wutkiewicz M; Jastrzebski Z; Czyzewska-Szafran H; Danysz A Acta Pol Pharm; 1992; 49(4):43-5. PubMed ID: 16092434 [TBL] [Abstract][Full Text] [Related]
35. Induction of bimodal programmed cell death in malignant cells by the derivative Ukrain (NSC-631570). Liepins A; Nowicky JW; Bustamante JO; Lam E Drugs Exp Clin Res; 1996; 22(3-5):73-9. PubMed ID: 8899308 [TBL] [Abstract][Full Text] [Related]
36. Study of acute toxicity of Ukrain in rats after intravenous injection. Kulik GI; Deneka ER; Todor IN; Karmozina LG Drugs Exp Clin Res; 1998; 24(5-6):287-93. PubMed ID: 10190089 [TBL] [Abstract][Full Text] [Related]
37. Amino acids and their derivatives in blood plasma of patients with breast cancer treated with Ukrain. Part V. Nefyodov LI; Uglyanica KN; Smirnov VY; Doroshenko YM; Fomin KA; Nowicky JW; Brzosko WJ Drugs Exp Clin Res; 1996; 22(3-5):155-7. PubMed ID: 8899320 [TBL] [Abstract][Full Text] [Related]
38. Intermittent three-month treatment with Ukrain in intact and ovariectomized rats. Part I: Effect on selected biomechanical parameters of the femur. Jabłoński M; Gorzelak M; Patyra M; Jagiełło-Wójtowicz E Drugs Exp Clin Res; 2000; 26(5-6):321-5. PubMed ID: 11345046 [TBL] [Abstract][Full Text] [Related]
39. Cysteine proteinase inhibitor level in tumor and normal tissues in control and cured mice. Poteryaeva ON; Falameyeva OV; Korolenko TA; Kaledin VI; Djanayeva SJ; Nowicky JW; Sandula J Drugs Exp Clin Res; 2000; 26(5-6):301-6. PubMed ID: 11345042 [TBL] [Abstract][Full Text] [Related]
40. Intermittent three-month treatment with Ukrain in intact and ovariectomized rats. Part III: Effect on the native electron paramagnetic resonance signal intensity of the femur. Jabłoński M; Korczak W; Gorzelak M; Jagiełło-Wójtowicz E Drugs Exp Clin Res; 2000; 26(5-6):333-6. PubMed ID: 11345048 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]